Evaluation of the Effectiveness of Ischemic Pre-conditioning on the Morbidity and Mortality of Open Surgery of Thoracoabdominal Aortic Aneurysms.
EPICATA
1 other identifier
interventional
65
1 country
1
Brief Summary
Patients having a planned open surgery of thoracoabdominal aortic aneurysms and enrolled in the study will be randomized the day of the surgery in 2 groups:
- Arm 1 : Patients with aortic clamping with pre-conditioning
- Arm 2 : Patients with aortic clamping without pre-conditioning Patients will be then followed, during 60 days after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2018
CompletedFirst Posted
Study publicly available on registry
October 24, 2018
CompletedStudy Start
First participant enrolled
July 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2023
CompletedSeptember 18, 2023
September 1, 2023
4 years
October 23, 2018
September 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
occurrence of a pulmonary complication
Need for prolonged invasive ventilation
Before the 48 hours after the beginning surgery
occurrence of a kidney complication
According to RIFLE criteria
During the 8 days after surgery
occurrence of a pulmonary complication
Occurrence of a moderate or severe acute respiratory distress syndrome (Berlin definition)
During the 8 days after surgery
occurrence of a pulmonary complication
Need for a new ventilation (invasive or not)
During the 48 hours after initial extubation
Secondary Outcomes (5)
Pulmonary Morbidity
During the 21 days after surgery
Kidney Morbidity
During the 21 days after surgery
Cardiac Morbidity
During the 48 hours after surgery
cell and tissue damage
During the 8 days after surgery
Death
During 60 days after surgery
Study Arms (2)
Arm 1
EXPERIMENTALPatients with aortic clamping withpre-conditioning
Arm 2
NO INTERVENTIONPatients with aortic clamping without pre-conditioning
Interventions
PCI procedure: clamping of the supracellular thoracic aorta for 5 minutes followed by a 5-minutes de-clamping period. PCI procedure is repeated twice.
Eligibility Criteria
You may qualify if:
- Patient \> 18 and \<85 years old
- Patient having a planned surgery for a thoracoabdominal aortic aneurysm by direct approach,
- Patient with aortic aneurysm requiring supra-visceral aortic clamping and visceral artery reconstruction,
- Aortic aneurysmal patient with or without distal femoral circulatory assistance,
- Patient with aortic aneurysm of atheromatous or dissecting etiology,
- Woman of childbearing potential with effective contraception (estrogen-progestin or intrauterine device or tubal ligation), postmenopausal woman (≥ 12 months of amenorrhea not induced by therapy)
- Patient who read and understood the newsletter and signed the consent form
- Patient affiliated with a social security scheme
You may not qualify if:
- Patient with aortic aneurysms requiring supra-visceral aortic clamping but not requiring visceral artery reconstruction (supra-visceral aortic clamping for renal aortic juxtaposition aorta),
- Patient with thoraco abdominal aortic aneurysms requiring a circulatory arrest (aortic aneurysms affecting the descending thoracic aorta or the aortic arch)
- Patient requiring emergency aortic surgery
- Patient under treatment known as interfering with PCI (Nicorandil or oral antidiabetic agents),
- Pregnant or lactating woman (negative result of baseline blood test)
- Participation in another interventional study within 28 days before randomization or during this study
- Person deprived of liberty by an administrative or judicial decision or person subject to a legal measure for the protection of adults,
- Patient under the protection of justice, patient under guardianship or curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital, Rouen
Rouen, 76031, France
Related Publications (2)
Liang F, Liu S, Liu G, Liu H, Wang Q, Song B, Yao L. Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD008472. doi: 10.1002/14651858.CD008472.pub3.
PMID: 36645250DERIVEDPalmier M, Bubenheim M, Chiche L, Chaufour X, Koskas F, Fadel E, Magnan PE, Ducasse E, Chakfe N, Steinmetz E, Dusseaux MM, Ricco JB, Plissonnier D. Protocol of supra-visceral aortic ischemic preconditioning for open surgical repair of thoracoabdominal aortic aneurysm : The EPICATA study (Evaluation of the Efficacy of Ischemic PreConditioning on morbidity and mortality in open ThoracoAbdominal Aortic surgery). BMC Surg. 2020 Aug 27;20(1):193. doi: 10.1186/s12893-020-00851-3.
PMID: 32854681DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2018
First Posted
October 24, 2018
Study Start
July 29, 2019
Primary Completion
July 11, 2023
Study Completion
July 29, 2023
Last Updated
September 18, 2023
Record last verified: 2023-09